
Will TLRY go back up?
The service's Tilray stock prediction was that by April 2027 the stock would be effectively worthless. Meanwhile, forecasting service AIPickup's TLRY stock forecast is relatively flat, projecting that the price will reach $6.16 by 2025 and then land at $9.06 by 2030.
Is Tilray stock a good stock to buy?
The 2021 merger between two strong cannabis companies, Tilray (TLRY 1.77%) and Aphria, is turning out to be fruitful. Since the deal was completed, Tilray has reported impressive quarterly results. Its recent third quarter (ended Feb. 28) report had some brights spots for investors.
Is Tilray stock expected to rise?
The optimum price objective is $4.65137, with a projected gain this month. Therefore, $5.47 is the highest price objective, while $4.16 is the lowest. Tilray's stock is expected to rise in December 2022.
Should I hold or sell my Tilray stock?
The consensus among Wall Street analysts is that investors should "hold" Tilray stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares. View analyst ratings for Tilray or view top-rated stocks.
Why is GrowGeneration dropping?
GrowGeneration has lost much of its value for good reasons. Slow growth, low margins and generally unfavorable market conditions have all eaten away at share prices.
Will Tilray pay dividends?
TILRAY BRANDS (NASDAQ: TLRY) does not pay a dividend.
What do analysts say about Tilray stock?
The 16 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 7.00, with a high estimate of 23.00 and a low estimate of 2.60. The median estimate represents a +119.44% increase from the last price of 3.19.
What is the target price for Tilray?
Stock Price Target TLRYHigh$23.00Median$7.13Low$2.60Average$8.51Current Price$4.20
What is Nio price target?
NIO Inc (NYSE:NIO) The 31 analysts offering 12-month price forecasts for NIO Inc have a median target of 30.44, with a high estimate of 66.97 and a low estimate of 21.98.
Is Tilray a profitable company?
Tilray reported positive adjusted EBITDA of $10 million (12.5 million Canadian dollars) for the three months ended Feb. 28, about 24% lower than the previous quarter after its cannabis sales tumbled to $55 million in the three-month period.